The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function

Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis (RA), exhibits anti-inflammatory, antiproliferative and immunosuppressive effects. Although most of the beneficial effects of leflunomide have been attributed to its antimetabolite activity, main...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirsch, Bernhard M, Zeyda, Maximilian, Stuhlmeier, Karl, Grisar, Johannes, Smolen, Josef S, Watschinger, Bruno, Stulnig, Thomas M, Hörl, Walter H, Zlabinger, Gerhard J, Säemann, Marcus D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174963/
https://www.ncbi.nlm.nih.gov/pubmed/15899055
http://dx.doi.org/10.1186/ar1727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174963/
https://www.ncbi.nlm.nih.gov/pubmed/15899055
http://dx.doi.org/10.1186/ar1727

Ejemplares similares